title: Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management.
abstract: Basal cell carcinoma (BCC) is a heterogeneous malignant neoplasm with different biological and clinical behaviors, often slow growing and rarely metastatic and conveying an excellent prognosis. However, BCC is the most frequent skin cancer worldwide and can cause great morbidity, as most occur in high visible areas of the body, often relapse and may invade and destroy local tissues. This review aims to present a concise and updated overview of BCC histopathology and clinical presentation and progression. We also present a summary of currently available treatment options and some of the new promising agents.
authors.affiliation: Faculty of Medicine, Porto University, Praça de Gomes Teixeira, 4099-002 Porto, Portugal.
authors.forename: Tiago Ribeiro
authors.initials: TR
authors.lastname: Correia de Sá
authors.affiliation: Faculty of Medicine, Porto University, Praça de Gomes Teixeira, 4099-002 Porto, Portugal.
authors.forename: Roberto
authors.initials: R
authors.lastname: Silva
authors.affiliation: Faculty of Medicine, Porto University, Praça de Gomes Teixeira, 4099-002 Porto, Portugal.
authors.forename: José Manuel
authors.initials: JM
authors.lastname: Lopes
mesh_terms: D002280:Basal Cell Carcinoma / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy*; D019468:Disease Management; D018450:Disease Progression; D006801:Humans; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy*
keywords: basal cell carcinoma; diagnosis; histopathology; prognosis; treatment